Safety and efficacy of addition of sitagliptin to rapid-acting insulin secretagogues for glycemic control, including post-prandial hyperglycemia, among Japanese with type 2 diabetes mellitus.

Autor: Tajima N; 1Jikei University School of Medicine, Tokyo, Japan., Kadowaki T; 2Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Odawara M; 3The Department of Diabetology, Endocrinology, Metabolism and Rheumatology, Tokyo Medical University, Tokyo, Japan., Minamide T; 4Ono Pharmaceutical Co., Ltd., 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, 541-8564 Japan., Seki A; 4Ono Pharmaceutical Co., Ltd., 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, 541-8564 Japan., Oki K; 4Ono Pharmaceutical Co., Ltd., 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka, 541-8564 Japan., Nagayasu R; MSD K.K., Tokyo, Japan., Ferreira JCA; 6Merck Sharp & Dohme Corp., Rahway, NJ USA.

Publikováno v: Diabetology international [Diabetol Int] 2015 Aug 28; Vol. 7 (2), pp. 155-166. Date of Electronic Publication: 2015 Aug 28 (Print Publication: 2016).